Robert Putnak

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Katrin Ramsauer, Michael Schwameis, Christa Firbas et al. · The Lancet Infectious Diseases · 2015 · 227 citations

Vaccination, Vaccine Safety, Vaccinology +6

Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance

Stephen J. Thomas, Ananda Nisalak, Kathryn B. Anderson et al. · American Journal of Tropical Medicine and Hygiene · 2009 · 222 citations · Full text

Sequence analysis of cloned dengue virus type 2 genome (New Guinea-C strain)

K. Irie, Prem Mohan, Yasuyuki Sasaguri et al. · Gene · 1989 · 180 citations

Genetics, Sequence Analysis, New Guinea-c Strain +6

PHASE I TRIAL OF 16 FORMULATIONS OF A TETRAVALENT LIVE-ATTENUATED DENGUE VACCINE

Robert Edelman, Steven S. Wasserman, Sacared A Bodison et al. · American Journal of Tropical Medicine and Hygiene · 2003 · 169 citations

Vaccination, Formulations 1-15, Vaccine Development +14

Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

Robert Putnak, Dave Barvir, Jeanne Burrous et al. · The Journal of Infectious Diseases · 1996 · 166 citations · Full text

Vaccination, Vaccine Development, Rhesus Monkeys +11